Blood Glucose Regulation And Diabetes Eug Ackerman

Type 2 Diabetes Defeated

Treatment for Diabetes

Get Instant Access

Effect of excessive weight gain with intensive therapy of type I diabetes on lipid levels and blood pressure: results from the DCCT. JAMA 280(2): 140-146, 1998.

8. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46(2):271-286, 1997.

9. Reichard P, Nilsson BY, Rosenqvisc (J. The effect oT long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993.

10. Reichard P, Pihl M. Mortality and Lreaiment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes 43(2):313—317, 1994.

11. Cox DJ, Gonder-Frederick LA. Kovatchev BP, Young-Hyman DL, Donner TW, Julian DM, Clarke WL. Biopsychobehavioral model of severe hypoglycemia. 1!. Understanding the risk of severe hypoglycemia. Diabetes Care 22( 12):2018-2025, 1999.

12. Kinsley BT, Weinger K, Bajaj M, Levy CJ, Simonson DC, Quigley M, Cox DJ, Jacobson AM. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in lype 1 diabetes. Diabetes Care 22(7): 10221028, 1999.

13. Deary 1J, Crawford JR, Hepburn DA, Langan SJ, Blackmore LM, Frier BM. Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 42(2):341-344, 1993.

14. Perros P, Deary IJ, Sellar RJ. Best JJ, Frier BM. Brain abnormalities demonstrated by magnetic resonance imaging in adult EDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20(6): 1013-1018, 1997.

15. Fujioka M, Okuchi K, Hjramatsu KJ, Sakakj T, Sakaguchi S, Ishii Y. Specific changes in human brain after hypoglycemic injury. Stroke 28(3):584-587, 1997.

16. Kaufman FR, Epport K, Engilman R, Halvorson M. Neurocogniijve functioning in children diagnosed with diabetes before age 10 years. J Diabetes Complications 13(l):3l-38, 1999.

17. Rovet JF, Ehrlich RM. The effect of hypoglycemic seizures on cognitive function in children with diabetes: a 7-year prospective study. J Pediatr I34(4):503-506, 1999.

18. Rovet JF, Ehrlich RM, Czuchta D. intellectual characteristics of diabetic children at diagnosis and one year later. J Pediatr Psychol 15: 775-788, 1990.

19. Strachan MW, Deary IJ, Ewing FM, Frier BM. Recovery of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes. Diabetes Care 23(3):305-3l2, 2000.

20. Gold AE, MacLeod KM, Deary I J, Frier BM. Hypoglycemia-induced cognitive dysfunction in diabetes mellitus: effect of hypoglycemia unawareness. Physiol Behav 58(3):501-511, 1995.

21. Marques JL, George E, Peacey SR, Harris ND, Macdonald IA, Cochrane T, Heller SR. Altered ventricular repolarization during hypoglycaemja in patients with diabetes. DiabetMed l4(8):648-654, 1997.

22. Trovati M, Anfossi G, Cavalot F. Vnali S, Massucco P, Mularoni E, Schinco P, Tamponi G, Emanuelli G. Studies on mechanisms involved in hypoglycemia-induced platelet activation. Diabetes 35(7):818-825, 1986.

23. Duh E, Felnglos M. Hypoglycemia-induced angina pectoris in a patient with diabetes mellitus. Ann Intern Med 44<7):751-755, 1996.

24. Kamijo Y, Soma K. Aoyama N, Fukuda M, Ohwada T. Myocardial infarction with acute insulin poisoning—a case report. Angiology 51 (S):689—693, 2000.

25. Sovik 0, Thordarson H. Dead-in-bcd syndrome in young diabetic patients. Diabetes Care 22(suppl. 2).B40-B42, 1999.

26. Heller SR. Diabetic hypoglycaemia. Best Pract Res Clin Endocrinol Metab 13(2)'. 279-294, 1999.

27. SpyerG, Hattersley AT, Macdonald IA, Amiel SA, MacLeod KM. Hypoglycaemic counter-regulation ai normal blood glucose concentrations in patients with well controlled type-2 diabetes. Lancet 356: 1970-1974, 2000.

28. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28(2): 103-117, 1995.

29. Matyka K, Evans M, Lomas J.Cranston I. Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 20(2): 135-141, 1997.

30. Shorr RJ. Ray WA. Daugherty JR. Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med I57(15):I68I-1686, 1997.

31. Veneman TF, Erkelens DW. Clinical review: hypoglycemia unawareness in nonin-sulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82(6): 1682-1684, 1997.

32. Bolli GB, Tsitiikian E, Haymond MW, Cryer PE, Gerich IE. Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus: paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions. J Clin Invest 73:1532-1541, 1984.

33. Shamoon H, Friedman S, Canton C, Zacharowicz L, Hu M, Rossetti L. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus. J Clin invest 93(6):2562-257l. 1994.

34. Ohno T, Toyama T, Hoshizaki H, Okamoio E, Naito S, Nogami A, Kamiyama H, Ohshima S, Yuasa K, Taniguchi K, et al. Evaluation of cardiac sympathetic nervous function by 1231-metaiodobenzylguanidine scintigraphy in insulin-treated non-insulin dependent diabetics with hypoglycemia unawareness. Intern Med 35(2):94-99, 1996.

35. Hepburn DA, MacLeod KM, Pell AC, Scougal IJ, Frier BM. Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med 10(3):231-237, 1993.

36. Panel 11 CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, et al. Meticulous prevention of hypoglycemia normalizes ihe glycemic thresholds and magnitude of most of neuroendocrine responses to. symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42(11): 1683-1689, 1993.

37. Cryer PE. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM: a vicious cycle. Diabetes 41 (3):255-260, 1992.

38. McCall AL. IDDM, counierregulaiion, and the brain. Diabetes Care 20(8): 12281230, 1997.

39. Boyle PJ, Nagy RJ, O'Connor AM, Kempers SF, Yeo RA, Quails C. Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci USA 9l(20):9352-9356, 1994.

40. Boyle PJ, Kempers SF, O'Connor AM, Nagy RJ. Brain glucose upiake and un-awareness of hypoglycemia in patients with insulin-dependent diabetes melliius. N Engl J Med 333(26): 1726-1731, 1995.

41. Davis SN, Shavers C. Davis B. Costa F. Prevention of an increase in plasma Cortisol during hypoglycemia preserves subsequent counterregulaiory responses. J Clin invest 100(2):429-438, 1997.

42. Davis SN, Shavers C, Costa F, Mosqueda-Garcia R. Role of Cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest 98(3):680-691, 1996.

43. Fritsche A, Stumvoll M, Haring HU, Gench JE. Reversal of hypoglycemia un-awareness in a long-term type I diabetic patient by improvement of beta-adrenergic sensitivity after prevention of hypoglycemia. J Clin Endocrinol Metab 85(2):523-525. 2000.

44. Fritsche A, Srumvoll M, Grub M, Sieslack S, Renn W, Schmulling RM, Haring HTJ, Gerich IE. Effect of hypoglycemia on beta-adrenergic sensitivity in norma] and type I diabetic subjects. Diabetes Care 21(9): 1505-1510, 1998.

45. George E, Marques JL, Harris ND. Macdonald I A, Hardisty CA, Heller SR. Preservation of physiological responses to hypoglycemia 2 days after antecedent hypoglycemia in patients with IDDM. Diabetes Care 20(8): 1293-1298, 1997.

46. Bolli GB. How to ameliorate the problem of hypoglycemia in intensive as well as noniniensive treatment of type I diabetes. Diabetes Care 22 (suppl 2): B43-52,1999.

47. Fanelli C, Pampanelli S, Lalli C, Del Sindaco P, Ciofena M, Lepore M, Porcellau F, Boitini P, Di Vincenzo A, Bruneiti P, et al. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes 46(7): 1172-1181, 1997.

48. Veneman T, Mirrakou A, Mokan M, Cryer P, Gerich J. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 42(9): 1233-1237. 1993.

49. Saleh TY, Cryer PE. Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM. Diabetes Care 20(8): 1231-1236, 1997.

50. Kaufman FR, Devgan S. Use of uncooked cornstarch to avert nocturnal hypoglycemia in children and adolescents with type I diabetes. J Diabetes Complications 10(2): 84-87, 1996.

51. Beregszaszi M, Tubiana-Rufi N, Benali K, Noel M, Bloch J, Czernichow P. Nocturnal hypoglycemia in children and adolescents with insulin-dependent diabetes melli-tus: prevalence and risk factors. J Pediatrics l3l(l):27-33, 1997.

52. Matyka KA, Crowne, Havel PJ, Macdonald !A, Matthews D, Dunger DB. Counter-regulation during spontaneous nocturnal hypoglycemia in prepubertal children with type I diabetes. Diabetes Care 22(7):l 144-1150, 1999.

53. Rabasa-Lhoret R, Ducros F, Bourque J. Chiasson JL. Guidelines for premeal Insulin dose reduction for postprandial exercise of different intensities and durations in type I diabetic subjects treated intensively with a basal-bolus insulin regimen (Ultralente-Lispro). Diabetes Care 24: 625-630, 2001.

54. Gearhart JG, Duncan JL 3rd, Replogle JH, Forbes RC, Walley EJ. Efficacy of slid-ing-scale insulin therapy: a comparison with prospective regimens. Fam Pract Res J 14(4):313—322, 1994.

55. Sawin CT. Action without benefit: the sliding scale of insulin use. Arch Intern Med 157(5):489, 1997.

56. Guthrie DW, Guthrie RA. Approach to management. Diabetes Educator 16(5):401-406, 1990.

57. Silverstein JH. Rosenbloom AL. New developments in type ) (insulin-dependent) diabetes. Clin Pediair 39(5):257-266, 2000.

58. Garg SK, Potts RO, Ackerman NR, Fermi SJ, Tamada JA, Chase HP. Correlation of fingerstick blood glucose measurements with GlucoWaich biographer glucose results in young subjects with type I diabetes. Diabetes Care 22(10): L708—17L4,


59. Jones TW, Caprio S, Diamond MP. Hallarman L. Boulware SD, Sherwin RS, Tam-borlane WV. Does insulin species modify counterregulatory hormone response to hypoglycemia? Diabetes Care 14(8):728-731, 1991.

60. Riddle MC. Schneider J. Glimepiride Combination Group. Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Diabetes Care 21(7): 1052-1057, 1998.

61. PieberTR, Eugene-Jolchine I, Derobert E. The European Study Group of HOE 901 in Type I Diabetes: eFficacy and safely of HOE 901 versus NPH insulin in patients with type I diabetes. Diabetes Care 23(2): 157-162, 2000.

62. Ratner RE, Hirsch 18, Neifing JL, Garg SK, Mecca TE, Wilson CA. U.S. Study Group of Insulin Glargine in Type I Diabetes. Less hypoglycemia with insulin glar-gine in intensive insulin therapy for type 1 diabetes. Diabetes Care 23(5):639-643,


63. Campbell PJ, Bolli GB,Gerich JE. Prevention of the dawn phenomenon (early morning hyperglycemia) in insulin-dependent diabetes melliius by bedtime intranasal administration of a long-acting somatostatin analog. Metabolism: Clin Fxp 37(l):34-37, 1988.

64. Bolli GB, Perriello G. Faneili CG, De Feo P. Nocturnal blood glucose control in type ! diabetes mellitus. Diabetes Care I6(suppl 3):7l-89, 1993.

65. Yki-Jarvinen H, Ryysy L, Nikkila K, Tulokas T, Vanamo R, Heikkila M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med I30(5):389 396, 1999.

66. Polonsky KS, Sturis J, Bell Gl. Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334(12):777-783, 1996.

67. Dirrutnadis GD. Gerich JE. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 6:374377, 1983.

Was this article helpful?

0 0
101 Everyday Tips for Losing 10 Pounds

101 Everyday Tips for Losing 10 Pounds

Studies show obesity may soon overtake tobacco as the leading cause of death in world. Who Else Could Use 101 'Everyday' Ways to Lose 10 Pounds or more and Keep it Off! You've been putting it off too long. Hey, everyone needs to lose weight from time to time. You're no different!

Get My Free Ebook

Post a comment